Developing CAR-T Cell Therapies?
Support your cancer immunotherapy development with our new CAR-T Target Luciferase Reporter Cells. Be sure to also join our poster session on November 10 at SITC 2022 to check out our application data.
Attend our 3-D Airway Model Webinar
Join our webinar on October 6 to learn how to reliably generate 3-D airway models with consistent full epithelial differentiation for your drug development studies, toxicological testing, and basic research.
Read our New Application Note
Check out the application data for our quantitative synthetic Monkeypox virus DNA standard.
Join our Presentation
Join our presentation on October 14 at ASIC 2022 to learn about our method for producing highly purified exosomes.
Join our poster sessions
Join our poster sessions on October 18 at ASM NGS 2022 to learn about our bioinformatics pipeline for assembling and annotating whole-genome sequencing data.
ATCC's Podcast Season 1 Episodes Recap
In each episode, ATCC scientists share their personal and professional journeys.
Assay development resources
SARS-CoV-2 molecular diagnostics development
For SARS-CoV-2 molecular diagnostics manufacturers moving from emergency use authorization (EUA) to 510(k) premarket submission to the US Food & Drug Administration (FDA), robust testing must be performed to demonstrate that the device is safe and effective as well as substantially equivalent to legally marketed devices. To support these validation studies, ATCC provides an extensive array of authenticated and clinically relevant strains and genomic and synthetic nucleic acids for evaluating limit of detection, inclusivity, and cross-reactivity.Develop your SARS-CoV-2 Assay
Monkeypox virus molecular diagnostics development
Accurate and rapid diagnosis of monkeypox is critical for timely healthcare and tracking of transmission. To support the need for increased monitoring, ATCC provides a variety of orthopoxviruses and nucleic acids that support assay development and validation. We have also developed a research use only (RUO) quantitative synthetic monkeypox virus DNA preparation with a sequence design based on several published assays.Develop your monkeypox assay
Human Cancer Models Initiative
ATCC is collaborating with the Human Cancer Models Initiative (HCMI) to offer scientists a wide variety of next-generation 2-D and 3-D patient-derived in vitro cancer models, including organoids. ATCC is committed to making available a growing collection of models generated by the HCMI, which will include both common as well as rare and understudied examples of cancer from numerous tissues. These HCMI models are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research.Find next-generation models
Advanced Biological Models for Cancer Research
ATCC Genome Portal
Enhanced Authentication Initiative
ATCC is not only enriching the characterization of our biological collections by using next-generation sequencing, we are also making those data available to everyone through the ATCC Genome Portal.
ATCC Genome Portal
The ATCC Genome Portal makes it easy to find the high-quality whole-genome sequencing data needed for your research. Using your ATCC login, you can easily search, download, and analyze hundreds of high quality genomes.
ATCC (American Type Culture Collection) is a nonprofit, global biological resource center and standards organization and the leading developer and supplier of authenticated cells lines and microorganisms. We leverage our rich history and knowledge to provide the products, services, and resources scientists need to conduct critical life science research.